Acquired by New Relic.
Animab develops antibodies to tackle gastrointestinal pathogens in livestock.
ABSCINT is developing single-domain antibodies for disease diagnosis through imaging.
Aloxy’s Internet of Things technology is enabling the petrochemical industry to innovate.
